Biotech companies have had a strong, multi-year run that was supercharged by the response of the sector to the pandemic with its development of the Covid vaccines and therapies. The speed and success ...

Regional Bioscience Companies to Give Presentations on Their Leading Technologies and Assets on October 27 and 28 at the Pennsylvania Convention Center in Philadelphia These companies, which are ...

BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will showcase its ...

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today issued a call for presentations for the 2018 BIO World Congress on Industrial Biotechnology. The 15 th annual BIO ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, ...

ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the ...

SANTA ANA, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and ...

Agios Pharmaceuticals Inc AGIO announced updated data from the Phase 1 study evaluating mitapivat in adults with sickle cell disease showing, as of the data cut-off, six of 11 efficacy evaluable ...

Leap Therapeutics Inc LPTX said the FDA U.S. Food and granted orphan drug designation for its DKN-01 for the treatment of gastric and gastroesophageal junction cancer. The company said DKN-01 is ...

This press release contains forward-looking statements about Sana Biotechnology, Inc. (the “Company,” “we,” “us,” or “our”) within the meaning of the federal securities laws, including those related ...

, a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that they will present at the The convention, designed ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...